Safety profiling of pioglitazone and telmisartan combination by sub-chronic toxicity study in rat
It has been reported that the major cause of mortality in diabetes is cardiovascular diseases and contribution of hypertension is significant in this context. Pioglitazone, a thiazolidinedione class of therapeutic agent is used to treat type 2 diabetes mellitus. Telmisartan, an angiotensin recepto...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Elsevier
2016
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/52030/ http://irep.iium.edu.my/52030/ http://irep.iium.edu.my/52030/ http://irep.iium.edu.my/52030/1/Toxicity_Pio%20Tel_Pinaki%20paper.pdf http://irep.iium.edu.my/52030/7/52030-Safety%20profiling%20of%20pioglitazone%20and%20telmisartan%20combination%20by%20sub-chronic%20toxicity%20study%20in%20rat_SCOPUS.pdf |
Internet
http://irep.iium.edu.my/52030/http://irep.iium.edu.my/52030/
http://irep.iium.edu.my/52030/
http://irep.iium.edu.my/52030/1/Toxicity_Pio%20Tel_Pinaki%20paper.pdf
http://irep.iium.edu.my/52030/7/52030-Safety%20profiling%20of%20pioglitazone%20and%20telmisartan%20combination%20by%20sub-chronic%20toxicity%20study%20in%20rat_SCOPUS.pdf